PROFUND ADVISORS LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 224 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2024$1,952,327
+25.7%
18,114
+10.6%
0.07%
+20.0%
Q1 2024$1,553,333
-18.4%
16,375
-20.6%
0.06%
-26.8%
Q4 2023$1,902,727
+32.2%
20,628
-28.0%
0.08%
+2.5%
Q3 2023$1,439,456
-13.9%
28,663
+8.4%
0.08%
-11.1%
Q2 2023$1,670,882
+21.4%
26,438
-13.6%
0.09%
+5.9%
Q1 2023$1,376,694
+288.0%
30,600
+277.9%
0.08%
+269.6%
Q4 2022$354,773
-32.0%
8,098
+2.1%
0.02%
-39.5%
Q3 2022$522,000
+27.9%
7,928
-1.8%
0.04%
+46.2%
Q2 2022$408,000
-29.5%
8,077
-10.9%
0.03%
+8.3%
Q1 2022$579,000
-46.3%
9,062
-10.0%
0.02%
-31.4%
Q4 2021$1,079,000
-6.4%
10,070
-10.2%
0.04%
-10.3%
Q3 2021$1,153,000
+12.3%
11,211
-4.0%
0.04%
+14.7%
Q2 2021$1,027,000
-11.2%
11,675
-1.9%
0.03%
-22.7%
Q1 2021$1,157,000
-17.7%
11,902
-5.1%
0.04%
-27.9%
Q4 2020$1,406,000
+34.7%
12,537
+11.3%
0.06%
+13.0%
Q3 2020$1,044,000
+3.7%
11,261
-12.8%
0.05%
-3.6%
Q2 2020$1,007,000
+72.4%
12,910
+29.3%
0.06%
+27.3%
Q1 2020$584,000
-48.2%
9,985
-29.1%
0.04%
-10.2%
Q4 2019$1,128,000
+24.5%
14,078
+14.2%
0.05%
+6.5%
Q3 2019$906,00012,3290.05%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2019
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 559,381$41,098,00015.69%
Casdin Capital, LLC 940,000$69,061,800,0007.15%
Ghost Tree Capital, LLC 325,000$23,878,0006.08%
CADIAN CAPITAL MANAGEMENT, LP 1,418,704$104,232,0004.96%
DAFNA Capital Management LLC 123,218$9,053,0003.40%
BVF INC/IL 437,565$32,148,0003.38%
Opaleye Management Inc. 105,000$7,714,0002.79%
Cormorant Asset Management, LP 493,000$36,221,0002.20%
Novo Holdings A/S 170,667$12,539,0002.15%
Artal Group S.A. 600,000$44,082,0001.77%
View complete list of BLUEPRINT MEDICINES CORP shareholders